Transcapillary transport of metaiodobenzylguanidine (MIBG) in isolated rat heart.
A better understanding of transcapillary transport for tracer metaiodobenzylguanidine (MIBG) is desirable for development of tracer kinetic models that yield meaningful estimates of neuronal uptake function from tissue radioactivity time courses. This study utilized a multiple-indicator approach in Langendorff-perfused rat hearts to define transport mechanisms and determine the capillary permeability-surface area (PSc) over a broad range of flow (F). Multiple injections within the same heart at different flows allowed characterization of the PSc/F relationship within the same heart. The coefficient of variation of E for multiple injections within the same hearts at constant flow was 6 +/- 2% (3 to 6 injections in 9 hearts). In 10 hearts (4 to 6 injections per heart), flow was varied between 2.0-16.5 mL/min. PSc was found to be nearly proportional to flow in each heart (r = 0.88 +/- 0.14; slope = 0.23 +/- 0.10; intercept = 11 +/- 7 mL/min/g dry). Tissue hypoxia at low flows, as evidenced by enhanced lactate production, did not appear to influence the PSc/F relationship. Pharmacologic blockade of uptake-1 and uptake-2 had negligible affect on E or PSc as compared with flow-matched controls, although tissue retention was markedly reduced. The results show PSc of MIBG to be nearly proportional to flow but independent of specific neuronal and extraneuronal transport mechanisms and tissue hypoxia. The results are consistent with a passive diffusion process across the capillary endothelial barrier. The increase in PSc with increasing flow could reflect capillary recruitment and/or enhanced capillary permeability.
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA. trd@petsparc.mc.duke.edu
T R
TR
DeGrado
S
S
Wang
D019797:3-Iodobenzylguanidine / Q000493:pharmacokinetics*; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002199:Capillary Permeability; D003326:Coronary Circulation / Q000502:physiology; D005260:Female; D000860:Hypoxia / Q000378:metabolism; D066298:In Vitro Techniques; D019344:Lactic Acid / Q000097:blood; D009206:Myocardium / Q000378:metabolism*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results; D012711:Serum Albumin, Radio-Iodinated / Q000493:pharmacokinetics
D019275:Radiopharmaceuticals; D012711:Serum Albumin, Radio-Iodinated; D019344:Lactic Acid; D019797:3-Iodobenzylguanidine